BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:aritinercept readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of aritinercept\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07596901-10864@assetmemo.bio
DTSTAMP:20261121T004055Z
DTSTART;VALUE=DATE:20290302
DTEND;VALUE=DATE:20290303
SUMMARY:aritinercept: Phase 1/2 readout est. (NCT07596901)
DESCRIPTION:aritinercept\, phase 1/2\, Generalized Myasthenia Gravis.\nStud
 y: Study of Aritinercept in Patients With Generalized Myasthenia Gravis\nE
 stimated primary completion: 2 March 2029. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/aritinercept#upcoming-events\nRegistry record: https
 ://clinicaltrials.gov/study/NCT07596901
URL:https://assetmemo.bio/drug/aritinercept#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
